CPH — Cipher Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- CA$204.91m
- CA$150.63m
- $21.16m
- 97
- 72
- 100
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 6.35 | 9.14 | 20.5 | 28.8 | 39.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8.88 | 9.22 | 6.66 | 6.8 | 5.09 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 17.2 | 20.1 | 29.3 | 38.2 | 48.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.2 | 1.91 | 0.501 | 0.481 | 0.402 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 46.5 | 44.3 | 51.7 | 73.8 | 86 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16.6 | 9.92 | 12.3 | 9.37 | 5.25 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 18.4 | 11.6 | 12.8 | 9.7 | 5.51 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 28 | 32.6 | 38.9 | 64.1 | 80.5 |
Total Liabilities & Shareholders' Equity | 46.5 | 44.3 | 51.7 | 73.8 | 86 |
Total Common Shares Outstanding |